Effect of Calories and Fat Content on the Pharmacokinetics of Lurasidone HCl
Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the effect of calorie and fat content on the
pharmacokinetics of Lurasidone HCl in subjects with schizophrenia, schizoaffective disorder,
or schizophreniform disorder.